Dna X (SONM) Consolidated Net Income (2018 - 2026)

Dna X has reported Consolidated Net Income for 9 years, with the latest figure at $10.3 million in Q1 2026.

• For the quarter ending Q1 2026, Consolidated Net Income rose 623.61% year-over-year to $10.3 million; the trailing twelve-month figure through Mar 2026 stood at $1.5 million (up 23.88% YoY), and the FY2025 full-year result was -$12.7 million, up 58.71% from the prior year.
• Consolidated Net Income for Q1 2026 stood at $10.3 million, up from $3.5 million in the prior quarter.
• The five-year high for Consolidated Net Income was $10.3 million in Q1 2026, with the low at -$7.5 million in Q2 2025.
• Historically, Consolidated Net Income has averaged -$824529.4 across 5 years, with a median of -$1.2 million in 2022.
• The largest YoY upside for Consolidated Net Income was 1134.22% in 2024 against a maximum downside of 1399.8% in 2024.
• Dna X's Consolidated Net Income stood at -$1.2 million in 2022, then gained by 26.14% to -$862000.0 in 2023, then jumped by 1134.22% to $8.9 million in 2024, then slumped by 61.26% to $3.5 million in 2025, then soared by 197.28% to $10.3 million in 2026.
• The last three Consolidated Net Income figures came in at $10.3 million (Q1 2026), $3.5 million (Q4 2025), and -$4.8 million (Q3 2025), per Business Quant data.